Broadleaf Partners, LLC Abbott Laboratories Transaction History
Broadleaf Partners, LLC
- $401 Million
- Q2 2024
A detailed history of Broadleaf Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Broadleaf Partners, LLC holds 5,811 shares of ABT stock, worth $683,606. This represents 0.15% of its overall portfolio holdings.
Number of Shares
5,811
Previous 5,811
-0.0%
Holding current value
$683,606
Previous $660,000
8.64%
% of portfolio
0.15%
Previous 0.17%
Shares
8 transactions
Others Institutions Holding ABT
# of Institutions
3,133Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$19.6 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.75 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.45 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.73 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...